Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
Drug Delivery Business1d
Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.
PODD Stock Gains Following the Launch of Omnipod 5 in Australia
Insulet announces the commercial launch of Omnipod 5 AID system in Australia, with Dexcom G6 and G7 CGM sensor compatibility.
MDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have Diabetes
The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Dexcom (DXCM) Gets a Buy from Wells Fargo
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...
Drug Delivery Business3d
Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care
DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe ...
MedPage Today on MSN4d
Type 2 Diabetes Patients Also Reap Benefits of Automated Insulin Delivery
An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using ...